| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Tubules, Collecting | 9 | 2019 | 46 | 2.670 |
Why?
|
| Polycystic Kidney Diseases | 10 | 2020 | 39 | 2.330 |
Why?
|
| Kidney | 13 | 2020 | 945 | 1.850 |
Why?
|
| TRPP Cation Channels | 6 | 2019 | 20 | 1.820 |
Why?
|
| Cilia | 11 | 2019 | 94 | 1.720 |
Why?
|
| Sodium-Calcium Exchanger | 6 | 2004 | 69 | 1.260 |
Why?
|
| Calcium | 13 | 2014 | 929 | 1.220 |
Why?
|
| Kidney Glomerulus | 6 | 2006 | 155 | 1.180 |
Why?
|
| Epithelial Cells | 6 | 2014 | 431 | 1.160 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 3 | 2020 | 25 | 0.950 |
Why?
|
| Juxtaglomerular Apparatus | 6 | 2008 | 7 | 0.920 |
Why?
|
| Glomerular Mesangium | 5 | 2004 | 53 | 0.900 |
Why?
|
| Kidney Tubules, Distal | 4 | 2008 | 15 | 0.860 |
Why?
|
| Animals | 46 | 2020 | 20880 | 0.820 |
Why?
|
| Cell Proliferation | 9 | 2018 | 1174 | 0.810 |
Why?
|
| Loop of Henle | 4 | 2008 | 6 | 0.810 |
Why?
|
| Periodicals as Topic | 2 | 2015 | 158 | 0.790 |
Why?
|
| Biomedical Research | 2 | 2015 | 310 | 0.740 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 4 | 2014 | 175 | 0.670 |
Why?
|
| Tumor Suppressor Proteins | 9 | 2019 | 194 | 0.640 |
Why?
|
| TRPV Cation Channels | 2 | 2019 | 17 | 0.630 |
Why?
|
| Kainic Acid | 2 | 2015 | 44 | 0.600 |
Why?
|
| Epidermal Growth Factor | 2 | 2014 | 95 | 0.560 |
Why?
|
| Cell Line | 10 | 2015 | 1752 | 0.530 |
Why?
|
| Angiotensinogen | 1 | 2015 | 18 | 0.530 |
Why?
|
| Cell Membrane Permeability | 2 | 2013 | 59 | 0.520 |
Why?
|
| Rabbits | 11 | 2008 | 509 | 0.510 |
Why?
|
| Nephrology | 1 | 2015 | 43 | 0.500 |
Why?
|
| Mice | 17 | 2020 | 8474 | 0.490 |
Why?
|
| Rats, Inbred Dahl | 6 | 2004 | 48 | 0.490 |
Why?
|
| Mechanotransduction, Cellular | 2 | 2011 | 27 | 0.480 |
Why?
|
| Marine Toxins | 1 | 2014 | 14 | 0.470 |
Why?
|
| Neuromuscular Junction | 1 | 2014 | 15 | 0.470 |
Why?
|
| ADAM Proteins | 1 | 2014 | 53 | 0.470 |
Why?
|
| Neuromuscular Depolarizing Agents | 1 | 2014 | 12 | 0.470 |
Why?
|
| Glycolysis | 1 | 2014 | 79 | 0.470 |
Why?
|
| Ciliary Motility Disorders | 1 | 2013 | 3 | 0.470 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2013 | 10 | 0.470 |
Why?
|
| Cell Polarity | 2 | 2013 | 49 | 0.460 |
Why?
|
| Sodium-Hydrogen Exchangers | 3 | 2014 | 43 | 0.460 |
Why?
|
| Calcium Channel Agonists | 1 | 2013 | 18 | 0.460 |
Why?
|
| Cell Communication | 2 | 2005 | 116 | 0.450 |
Why?
|
| Bronchiectasis | 1 | 2013 | 25 | 0.450 |
Why?
|
| Hyperglycemia | 1 | 2015 | 158 | 0.450 |
Why?
|
| Mice, Knockout | 6 | 2019 | 1692 | 0.440 |
Why?
|
| Calcium Signaling | 3 | 2019 | 97 | 0.430 |
Why?
|
| Cell Culture Techniques | 2 | 2010 | 189 | 0.420 |
Why?
|
| Angiotensin II | 4 | 2014 | 220 | 0.420 |
Why?
|
| Protein Isoforms | 5 | 2004 | 246 | 0.420 |
Why?
|
| Signal Transduction | 8 | 2015 | 2689 | 0.420 |
Why?
|
| Sodium | 6 | 2005 | 161 | 0.400 |
Why?
|
| Sodium Chloride | 4 | 2006 | 136 | 0.390 |
Why?
|
| Phosphatidylethanolamine Binding Protein | 1 | 2011 | 3 | 0.390 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2011 | 31 | 0.380 |
Why?
|
| Mutation | 2 | 2018 | 1213 | 0.380 |
Why?
|
| Receptors, Angiotensin | 2 | 2002 | 59 | 0.370 |
Why?
|
| Kidney Diseases | 1 | 2013 | 307 | 0.360 |
Why?
|
| Telomerase | 1 | 2010 | 85 | 0.350 |
Why?
|
| Adenosine Triphosphate | 4 | 2005 | 314 | 0.340 |
Why?
|
| Oxidative Stress | 2 | 2003 | 718 | 0.320 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2011 | 266 | 0.320 |
Why?
|
| Fluorescent Antibody Technique | 5 | 2013 | 282 | 0.310 |
Why?
|
| Renal Circulation | 3 | 2004 | 49 | 0.300 |
Why?
|
| Cells, Cultured | 7 | 2015 | 2673 | 0.290 |
Why?
|
| Feedback, Physiological | 2 | 2006 | 38 | 0.290 |
Why?
|
| Protein Kinase C | 5 | 2011 | 270 | 0.280 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2011 | 710 | 0.280 |
Why?
|
| Cell Size | 1 | 2006 | 76 | 0.280 |
Why?
|
| Phenotype | 3 | 2015 | 946 | 0.270 |
Why?
|
| Sodium-Potassium-Chloride Symporters | 2 | 2003 | 10 | 0.270 |
Why?
|
| Cytosol | 2 | 2003 | 123 | 0.260 |
Why?
|
| Osmolar Concentration | 4 | 2011 | 134 | 0.260 |
Why?
|
| Chloride-Bicarbonate Antiporters | 1 | 2004 | 4 | 0.250 |
Why?
|
| Antiporters | 1 | 2004 | 5 | 0.250 |
Why?
|
| Anion Transport Proteins | 1 | 2004 | 6 | 0.250 |
Why?
|
| Acid-Base Equilibrium | 1 | 2004 | 10 | 0.250 |
Why?
|
| Nephrons | 1 | 2004 | 17 | 0.250 |
Why?
|
| Vasoconstrictor Agents | 2 | 2003 | 107 | 0.250 |
Why?
|
| Paracrine Communication | 1 | 2004 | 31 | 0.240 |
Why?
|
| ErbB Receptors | 3 | 2014 | 239 | 0.230 |
Why?
|
| Membrane Potentials | 4 | 2019 | 200 | 0.230 |
Why?
|
| Up-Regulation | 4 | 2019 | 682 | 0.220 |
Why?
|
| Nitric Oxide Synthase | 1 | 2003 | 163 | 0.220 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2003 | 81 | 0.220 |
Why?
|
| Dinoprostone | 1 | 2003 | 110 | 0.210 |
Why?
|
| Disease Models, Animal | 6 | 2019 | 2550 | 0.210 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 2005 | 618 | 0.200 |
Why?
|
| H(+)-K(+)-Exchanging ATPase | 1 | 2002 | 45 | 0.200 |
Why?
|
| Aquaporin 2 | 2 | 2011 | 4 | 0.200 |
Why?
|
| Angiotensin Receptor Antagonists | 3 | 2014 | 155 | 0.200 |
Why?
|
| Proteomics | 2 | 2015 | 246 | 0.190 |
Why?
|
| Phosphorylation | 3 | 2014 | 1200 | 0.190 |
Why?
|
| Rats | 7 | 2004 | 5300 | 0.190 |
Why?
|
| Biological Transport | 4 | 2006 | 210 | 0.190 |
Why?
|
| Amino Acid Sequence | 4 | 2004 | 1082 | 0.180 |
Why?
|
| Organoids | 1 | 2020 | 42 | 0.180 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 35 | 0.180 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2020 | 18 | 0.180 |
Why?
|
| Respiratory Mucosa | 2 | 2013 | 52 | 0.180 |
Why?
|
| Enzyme Inhibitors | 4 | 2015 | 659 | 0.160 |
Why?
|
| Transcription Factors | 2 | 2014 | 753 | 0.160 |
Why?
|
| Protein Kinases | 1 | 2018 | 122 | 0.160 |
Why?
|
| Glomerular Filtration Rate | 3 | 2011 | 274 | 0.160 |
Why?
|
| Kidney Medulla | 2 | 2011 | 17 | 0.150 |
Why?
|
| Cloning, Molecular | 3 | 2004 | 357 | 0.150 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 248 | 0.150 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2015 | 201 | 0.150 |
Why?
|
| Energy Metabolism | 1 | 2018 | 222 | 0.140 |
Why?
|
| Glucose | 1 | 2018 | 307 | 0.140 |
Why?
|
| Immunohistochemistry | 3 | 2011 | 1174 | 0.140 |
Why?
|
| Base Sequence | 3 | 2004 | 1015 | 0.140 |
Why?
|
| Enzyme Activation | 4 | 2014 | 791 | 0.140 |
Why?
|
| Lisinopril | 1 | 2015 | 16 | 0.130 |
Why?
|
| Sea Lions | 1 | 2015 | 8 | 0.130 |
Why?
|
| Glutarates | 1 | 2015 | 6 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 1745 | 0.130 |
Why?
|
| Creatine Kinase | 1 | 2015 | 46 | 0.130 |
Why?
|
| Female | 8 | 2019 | 38021 | 0.130 |
Why?
|
| Cations, Divalent | 2 | 2013 | 27 | 0.130 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2004 | 2083 | 0.130 |
Why?
|
| Glutamine | 1 | 2015 | 45 | 0.130 |
Why?
|
| Wnt Proteins | 1 | 2015 | 57 | 0.130 |
Why?
|
| Centrioles | 1 | 2015 | 7 | 0.130 |
Why?
|
| Kidney Function Tests | 1 | 2015 | 114 | 0.130 |
Why?
|
| Humans | 17 | 2020 | 68549 | 0.120 |
Why?
|
| Angiomyolipoma | 1 | 2014 | 4 | 0.120 |
Why?
|
| Heparin-binding EGF-like Growth Factor | 1 | 2014 | 17 | 0.120 |
Why?
|
| ADAM17 Protein | 1 | 2014 | 28 | 0.120 |
Why?
|
| Tuberous Sclerosis | 1 | 2014 | 13 | 0.120 |
Why?
|
| Neurodegenerative Diseases | 1 | 2015 | 102 | 0.120 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2014 | 30 | 0.120 |
Why?
|
| Receptor, Angiotensin, Type 1 | 3 | 2014 | 80 | 0.120 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2015 | 114 | 0.120 |
Why?
|
| Fluorescent Dyes | 3 | 2006 | 191 | 0.120 |
Why?
|
| Mitochondrial Swelling | 1 | 2014 | 10 | 0.120 |
Why?
|
| Vacuoles | 1 | 2014 | 10 | 0.120 |
Why?
|
| Male | 6 | 2019 | 37283 | 0.120 |
Why?
|
| Morpholines | 1 | 2014 | 79 | 0.120 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 170 | 0.120 |
Why?
|
| Bronchoconstrictor Agents | 1 | 2013 | 6 | 0.120 |
Why?
|
| Genetic Testing | 1 | 2015 | 159 | 0.120 |
Why?
|
| Methacholine Chloride | 1 | 2013 | 20 | 0.120 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2015 | 135 | 0.120 |
Why?
|
| Receptors, Kainic Acid | 1 | 2014 | 24 | 0.120 |
Why?
|
| Random Allocation | 1 | 2015 | 442 | 0.120 |
Why?
|
| Mucociliary Clearance | 1 | 2013 | 21 | 0.120 |
Why?
|
| Mice, Inbred Strains | 1 | 2014 | 181 | 0.120 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 127 | 0.120 |
Why?
|
| Tetrazoles | 3 | 2014 | 160 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2014 | 114 | 0.110 |
Why?
|
| Intramolecular Oxidoreductases | 2 | 2003 | 10 | 0.110 |
Why?
|
| Extracellular Space | 2 | 2005 | 121 | 0.110 |
Why?
|
| Kidney Cortex | 2 | 2003 | 19 | 0.110 |
Why?
|
| Ion Channel Gating | 1 | 2013 | 42 | 0.110 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 132 | 0.110 |
Why?
|
| Pericytes | 1 | 2014 | 81 | 0.110 |
Why?
|
| Gene Silencing | 1 | 2013 | 137 | 0.110 |
Why?
|
| Cell Cycle Proteins | 1 | 2015 | 230 | 0.110 |
Why?
|
| Kidney Neoplasms | 1 | 2014 | 206 | 0.110 |
Why?
|
| HLA-D Antigens | 1 | 2012 | 20 | 0.110 |
Why?
|
| Furosemide | 2 | 2003 | 45 | 0.110 |
Why?
|
| Time Factors | 3 | 2019 | 4655 | 0.110 |
Why?
|
| In Vitro Techniques | 3 | 2014 | 765 | 0.110 |
Why?
|
| Kidney Tubules | 2 | 2010 | 80 | 0.100 |
Why?
|
| Triterpenes | 1 | 2012 | 40 | 0.100 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 247 | 0.100 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2014 | 331 | 0.100 |
Why?
|
| Receptors, Vasopressin | 1 | 2011 | 5 | 0.100 |
Why?
|
| Mice, Transgenic | 2 | 2014 | 1033 | 0.100 |
Why?
|
| Hemodynamics | 1 | 2015 | 705 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 786 | 0.100 |
Why?
|
| Kidney Concentrating Ability | 1 | 2011 | 3 | 0.100 |
Why?
|
| Hypertonic Solutions | 1 | 2011 | 17 | 0.100 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 1465 | 0.100 |
Why?
|
| Imidazoles | 2 | 2002 | 175 | 0.100 |
Why?
|
| Hypertrophy | 1 | 2011 | 89 | 0.100 |
Why?
|
| Kinetics | 2 | 2002 | 1047 | 0.090 |
Why?
|
| Rotation | 1 | 2011 | 58 | 0.090 |
Why?
|
| Serine | 1 | 2011 | 99 | 0.090 |
Why?
|
| Receptor, Angiotensin, Type 2 | 2 | 2002 | 31 | 0.090 |
Why?
|
| Autophagy | 1 | 2012 | 208 | 0.090 |
Why?
|
| Hippocampus | 1 | 2014 | 471 | 0.090 |
Why?
|
| Zebrafish Proteins | 1 | 2011 | 100 | 0.090 |
Why?
|
| Vesicular Transport Proteins | 1 | 2011 | 87 | 0.090 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2011 | 118 | 0.090 |
Why?
|
| Molecular Sequence Data | 2 | 2004 | 1446 | 0.090 |
Why?
|
| Biphenyl Compounds | 2 | 2002 | 184 | 0.090 |
Why?
|
| Benzimidazoles | 2 | 2002 | 128 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 2791 | 0.080 |
Why?
|
| Melanoma | 1 | 2012 | 335 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2011 | 954 | 0.080 |
Why?
|
| Fura-2 | 2 | 2006 | 21 | 0.080 |
Why?
|
| Membrane Transport Modulators | 1 | 2008 | 23 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2011 | 1040 | 0.080 |
Why?
|
| Liver | 1 | 2014 | 1118 | 0.080 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2008 | 27 | 0.080 |
Why?
|
| Isoenzymes | 2 | 2014 | 308 | 0.080 |
Why?
|
| Myocardium | 1 | 2014 | 1204 | 0.080 |
Why?
|
| Prostaglandin-E Synthases | 2 | 2003 | 6 | 0.070 |
Why?
|
| Osmotic Pressure | 1 | 2006 | 8 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2011 | 617 | 0.070 |
Why?
|
| Cell Differentiation | 1 | 2011 | 1034 | 0.070 |
Why?
|
| Regional Blood Flow | 1 | 2006 | 168 | 0.070 |
Why?
|
| Manganese | 1 | 2006 | 26 | 0.070 |
Why?
|
| Sodium Channels | 1 | 2005 | 24 | 0.070 |
Why?
|
| Polycystic Kidney, Autosomal Recessive | 1 | 2005 | 7 | 0.070 |
Why?
|
| Transfection | 2 | 2014 | 782 | 0.070 |
Why?
|
| Apoptosis | 1 | 2012 | 1641 | 0.070 |
Why?
|
| Thapsigargin | 1 | 2005 | 18 | 0.060 |
Why?
|
| Gadolinium | 1 | 2006 | 88 | 0.060 |
Why?
|
| Risk Factors | 1 | 2015 | 5720 | 0.060 |
Why?
|
| SLC4A Proteins | 1 | 2004 | 2 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 1070 | 0.060 |
Why?
|
| Trypsin | 1 | 2004 | 64 | 0.060 |
Why?
|
| Type C Phospholipases | 1 | 2004 | 67 | 0.060 |
Why?
|
| HEK293 Cells | 2 | 2018 | 326 | 0.060 |
Why?
|
| Indazoles | 1 | 2003 | 12 | 0.060 |
Why?
|
| Fluoresceins | 1 | 2003 | 31 | 0.060 |
Why?
|
| Antibodies | 1 | 2004 | 241 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2003 | 35 | 0.060 |
Why?
|
| Microsomes | 1 | 2003 | 31 | 0.060 |
Why?
|
| Nitric Oxide Donors | 1 | 2003 | 54 | 0.060 |
Why?
|
| RNA, Messenger | 2 | 2014 | 1663 | 0.060 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2003 | 50 | 0.060 |
Why?
|
| Opossums | 1 | 2003 | 7 | 0.060 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 73 | 0.060 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2003 | 112 | 0.060 |
Why?
|
| Peroxynitrous Acid | 1 | 2003 | 55 | 0.060 |
Why?
|
| Buffers | 1 | 2003 | 31 | 0.060 |
Why?
|
| Treatment Outcome | 1 | 2015 | 7028 | 0.060 |
Why?
|
| Arginine | 1 | 2003 | 102 | 0.050 |
Why?
|
| Ion Channels | 1 | 2003 | 72 | 0.050 |
Why?
|
| Hydrogen Peroxide | 1 | 2003 | 168 | 0.050 |
Why?
|
| Genome | 1 | 2003 | 54 | 0.050 |
Why?
|
| Cyclooxygenase 2 | 1 | 2003 | 160 | 0.050 |
Why?
|
| Astrocytes | 1 | 2005 | 270 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2002 | 165 | 0.050 |
Why?
|
| Hypertension | 2 | 2003 | 1533 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2002 | 230 | 0.050 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2002 | 10 | 0.050 |
Why?
|
| Glioblastoma | 1 | 2005 | 219 | 0.050 |
Why?
|
| Ethers, Cyclic | 1 | 2002 | 13 | 0.050 |
Why?
|
| Benzofurans | 1 | 2002 | 21 | 0.050 |
Why?
|
| Models, Biological | 2 | 2020 | 981 | 0.050 |
Why?
|
| Autocrine Communication | 1 | 2002 | 37 | 0.050 |
Why?
|
| Ouabain | 1 | 2002 | 32 | 0.050 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2002 | 72 | 0.050 |
Why?
|
| Diuretics | 1 | 2002 | 96 | 0.050 |
Why?
|
| Nitric Oxide | 1 | 2003 | 382 | 0.050 |
Why?
|
| Colon | 1 | 2002 | 168 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2002 | 261 | 0.050 |
Why?
|
| Interferon Regulatory Factors | 1 | 2020 | 24 | 0.050 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2000 | 138 | 0.050 |
Why?
|
| DNA | 1 | 2003 | 597 | 0.040 |
Why?
|
| Intracellular Membranes | 1 | 2000 | 86 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2000 | 93 | 0.040 |
Why?
|
| Pyridines | 1 | 2002 | 261 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 1 | 2000 | 196 | 0.040 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2018 | 6 | 0.040 |
Why?
|
| Tissue Engineering | 1 | 2020 | 212 | 0.040 |
Why?
|
| Gene Editing | 1 | 2018 | 33 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2000 | 524 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2003 | 1293 | 0.040 |
Why?
|
| Antihypertensive Agents | 1 | 2002 | 497 | 0.040 |
Why?
|
| Macrophages | 1 | 2020 | 647 | 0.030 |
Why?
|
| Glutaminase | 1 | 2015 | 7 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 1851 | 0.030 |
Why?
|
| Metabolomics | 1 | 2015 | 28 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2015 | 159 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2015 | 69 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2015 | 161 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2015 | 85 | 0.030 |
Why?
|
| Proteolysis | 1 | 2015 | 97 | 0.030 |
Why?
|
| Valine | 1 | 2014 | 43 | 0.030 |
Why?
|
| Valsartan | 1 | 2014 | 99 | 0.030 |
Why?
|
| Renin-Angiotensin System | 1 | 2014 | 78 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2015 | 235 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2012 | 76 | 0.030 |
Why?
|
| Isoquinolines | 1 | 2011 | 37 | 0.030 |
Why?
|
| Dogs | 2 | 2011 | 490 | 0.030 |
Why?
|
| Vasopressins | 1 | 2011 | 33 | 0.030 |
Why?
|
| Melanoma, Experimental | 1 | 2012 | 95 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2011 | 93 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2012 | 226 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2011 | 82 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2011 | 141 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 196 | 0.020 |
Why?
|
| Zebrafish | 1 | 2011 | 187 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2015 | 2455 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2011 | 328 | 0.020 |
Why?
|
| Infant | 1 | 2015 | 2891 | 0.020 |
Why?
|
| Protein Binding | 1 | 2011 | 1027 | 0.020 |
Why?
|
| United States | 1 | 2020 | 7338 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2011 | 597 | 0.020 |
Why?
|
| Amiloride | 1 | 2005 | 22 | 0.020 |
Why?
|
| Sodium Channel Blockers | 1 | 2005 | 23 | 0.020 |
Why?
|
| Epithelial Sodium Channels | 1 | 2005 | 25 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2005 | 160 | 0.020 |
Why?
|
| Peptide Hydrolases | 1 | 2005 | 82 | 0.020 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2005 | 23 | 0.020 |
Why?
|
| Intracellular Fluid | 1 | 2005 | 24 | 0.020 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2005 | 40 | 0.020 |
Why?
|
| Extravascular Lung Water | 1 | 2004 | 5 | 0.020 |
Why?
|
| Receptor, PAR-2 | 1 | 2004 | 7 | 0.020 |
Why?
|
| Leukocyte Elastase | 1 | 2004 | 19 | 0.020 |
Why?
|
| Receptor, PAR-1 | 1 | 2004 | 30 | 0.020 |
Why?
|
| Calcium Channels | 1 | 2005 | 59 | 0.020 |
Why?
|
| Electric Conductivity | 1 | 2004 | 87 | 0.020 |
Why?
|
| Bronchi | 1 | 2004 | 59 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2005 | 148 | 0.010 |
Why?
|
| Captopril | 1 | 2003 | 22 | 0.010 |
Why?
|
| Nifedipine | 1 | 2003 | 40 | 0.010 |
Why?
|
| Potassium | 1 | 2003 | 168 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 2003 | 204 | 0.010 |
Why?
|
| Calcium Channel Blockers | 1 | 2003 | 137 | 0.010 |
Why?
|
| Chlorides | 1 | 2002 | 68 | 0.010 |
Why?
|
| Adenosine Triphosphatases | 1 | 2002 | 83 | 0.010 |
Why?
|
| Luminescent Measurements | 1 | 2002 | 58 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2002 | 251 | 0.010 |
Why?
|
| Homeostasis | 1 | 1982 | 291 | 0.010 |
Why?
|
| Diet | 1 | 2003 | 514 | 0.010 |
Why?
|
| Feedback | 1 | 1982 | 90 | 0.000 |
Why?
|
| Vascular Resistance | 1 | 1982 | 179 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1982 | 1449 | 0.000 |
Why?
|